Webinar Recording: “Navigating the Evolving Regulatory Challenges for Silicone Materials in Medical Device Applications”

In this 40-minute presentation, Sabine Springael, DuPont’s Global Healthcare Product Steward & Regulatory Senior Consultant, explores the latest regulatory changes and toxicological considerations affecting the use of silicone materials in the global market. She also discusses how DuPont™ Liveo™ silicones can help ensure compliance while fostering innovation in this evolving industry landscape.

This recording is part of RDAbbott’s 2024 Webinar Series, which provides technical insights, material updates, and processing recommendations from our supplier partners.

Why You Should Watch and Listen

This webinar recording provides a comprehensive refresher about the European Chemicals Agency’s REACH program and its implications for selecting LSR and HCR materials for medical device applications. REACH is designed to protect human health and the environment, and its regulations span the supply chain from chemical substances to mixtures to articles.

Toxicological considerations and emerging global regulations that may affect silicones are also examined in this presentation.

Viewers will also learn how DuPont™ Liveo™ silicones comply with regulations and are suitable for a wide variety of medical device applications, including:

  • Short-term and long-term implanted devices
  • Medical and diagnostic devices and components
  • Non-implant external devices
About the Presenter

Sabine Springael joined Dow Corning in 1994 as a development chemist. After several years in R&D activities related to silicone chemistry, she joined the European regulatory group. She managed the EU chemical management compliance activities of Dow Corning before taking the role of EU Product Safety and Regulatory Compliance Group Leader. In 2017, Sabine was named Global Product Steward for the silicone healthcare business when this business was integrated into DuPont. In this position, Sabine is responsible for managing business risks associated with positioning DuPont’s silicone materials in the regulated healthcare market. In addition to guiding internal stakeholders to develop sustainable and compliant products, she assesses the suitability of DuPont’s products for final customer applications.

If you’re interested in learning more about DuPont’s versatile portfolio of LSR and HCR for medical devices, contact RDAbbott today.
To learn more about the other webinars in RDAbbott’s 2024 Webinar Series, visit RDAbbott.com/news/2024webinars.